Efficacy and tolerability of aripiprazole versus D2 antagonists in the early course of schizophrenia: a systematic review and meta-analysis
出版年份 2021 全文链接
标题
Efficacy and tolerability of aripiprazole versus D2 antagonists in the early course of schizophrenia: a systematic review and meta-analysis
作者
关键词
-
出版物
npj Schizophrenia
Volume 7, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-25
DOI
10.1038/s41537-021-00158-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antipsychotic Treatment effectiveness in First Episode of Psychosis: PAFIP 3-year follow-up randomized clinical trials comparing haloperidol, olanzapine, risperidone, aripiprazole, quetiapine and ziprasidone
- (2020) Marcos Gómez-Revuelta et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Clozapine-Associated Obsessive-Compulsive Symptoms and Their Management: A Systematic Review and Analysis of 107 Reported Cases
- (2020) David D. Kim et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia
- (2020) Nicholas Keks et al. CNS DRUGS
- Neurocognitive effects of atypical antipsychotics in patients with first-episode schizophrenia
- (2020) Yanyan Hou et al. NORDIC JOURNAL OF PSYCHIATRY
- A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis patients
- (2020) Javier Vázquez-Bourgon et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial
- (2019) Karsten Gjessing Jensen et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
- (2019) Maximilian Huhn et al. LANCET
- An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes
- (2019) Zhang Cheng et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms
- (2018) Michael Y. Guo et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Reversal of Dopamine Supersensitivity as a Mechanism of Action of Clozapine
- (2018) David D. Kim et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized study
- (2018) María Juncal-Ruiz et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis
- (2017) J. Vermeulen et al. PSYCHOLOGICAL MEDICINE
- Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment
- (2017) Maria Juncal-Ruiz et al. PSYCHOPHARMACOLOGY
- Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffective psychosis: Analysis of a randomized open-label 1 year study
- (2017) Benedicto Crespo-Facorro et al. SCHIZOPHRENIA RESEARCH
- The efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial
- (2017) Congjie Wang et al. Annals of General Psychiatry
- Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review
- (2016) John Yin et al. Current Neuropharmacology
- Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial
- (2015) Yoshiteru Takekita et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- P.3.d.035 Aripiprazole in treatment of first episode schizophrenia
- (2015) A. Kuzmanovic et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Efficacy and Safety of Paliperidone Extended Release in Adolescents With Schizophrenia: A Randomized, Double-Blind Study
- (2015) Adam J. Savitz et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Psychotropic dose equivalence in Japan
- (2015) Toshiya Inada et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes
- (2015) Delbert G. Robinson et al. SCHIZOPHRENIA BULLETIN
- Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method
- (2014) S. Leucht et al. SCHIZOPHRENIA BULLETIN
- Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12weeks of treatment in first treated episode of psychosis
- (2014) Rocio Pérez-Iglesias et al. SCHIZOPHRENIA RESEARCH
- Equipercentile linking of the BPRS and the PANSS
- (2013) S. Leucht et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia
- (2013) Arija Maat et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder
- (2013) Hiroyoshi Takeuchi et al. PSYCHOPHARMACOLOGY
- Treatment of first-episode non-affective psychosis: a randomized comparison of aripiprazole, quetiapine and ziprasidone over 1 year
- (2013) Benedicto Crespo-Facorro et al. PSYCHOPHARMACOLOGY
- Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: A 12-week randomized, flexible-dose, open-label trial
- (2013) Benedicto Crespo-Facorro et al. SCHIZOPHRENIA RESEARCH
- Efficacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first-episode schizophrenia through 52 weeks follow-up in China
- (2012) Yinbo Zhang et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis
- (2011) S. Tadokoro et al. SCHIZOPHRENIA BULLETIN
- Life expectancy among persons with schizophrenia or bipolar affective disorder
- (2011) Thomas Munk Laursen SCHIZOPHRENIA RESEARCH
- Aripiprazole versus haloperidol treatment in early-stage schizophrenia
- (2010) Ragy R. Girgis et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Aripiprazole in the Treatment of Depressive and Anxiety Disorders
- (2008) Chi-Un Pae et al. CNS DRUGS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started